<DOC>
	<DOC>NCT01195363</DOC>
	<brief_summary>To assess the acute and long-term bimodal efficacy of QTP, as an adjunct to ongoing treatment with lithium (Li) or divalproex (DIV) or lamotrigine (LAM) or any combination of the three thereof, in a group of patients with an index episode of a mixed state in BD.</brief_summary>
	<brief_title>Quetiapine Sr as Adjunctive Treatment In Mixed States of Bipolar Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Male or female; Age 18 years and older Patients on: Li at a stable dose for 4 weeks or longer, and a serum level at screening of 0.5 mEq/l OR DIV dose for 4 weeks or longer, and a serum level at screening of 45 g/ml OR LAM (dosage/day â‰¥100mg) at a stable dose for 4 weeks or longer OR Any combination 3a, 3b, or 3c Patients meeting DSMIV TR diagnosis of bipolar disorder, I or II, as assessed using the MINI, (Sheehan et al., 1998) PLUS any ONE of criteria 5 or 6 or 7 Patients meeting DSMIV TR diagnostic criteria for a mixed manic episode with Young Mania Rating Scale (YMRS) score&gt;/=14 and Montgomery Asberg Depression Rating Scale (MADRS) score&gt;/=14 Patients meeting the criteria for a manic/hypomanic episode for at least 2 days with the simultaneous presence of Young Mania Rating Scale (YMRS) score&gt;/=14 PLUS Montgomery Asberg Depression Rating Scale (MADRS) score&gt;/=14 ; Patients meeting DSMIV TR diagnostic criteria for a major depressive episode with the simultaneous presence of MADRS score&gt;/=14 PLUS meeting the criteria for a manic/hypomanic episode for at least 2 days with the simultaneous presence of Young Mania Rating Scale (YMRS) score&gt;/=14 Patients with a current Axis I diagnosis of schizophrenia, schizophreniform disorder, schizotypal disorder, bipolar disorder with psychotic subtype, drug induced mania or AIDS induced mania Women with a positive pregnancy test or who are lactating Women of childbearing potential who are not practicing a clinically accepted method of contraception Patients with general medical conditions that contraindicate psychoactive medications or uncontrolled medical disorder or central nervous system diseases. Patients whose clinical status requires inpatient or day hospital treatment History of severe side effects associated with therapeutic doses of Li, DIV, LAM Alcohol or drug dependent at time of enrollment Suicidal at time of enrollment. Current or previous exposure to QTP</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>bipolar disorder, mania, depression</keyword>
</DOC>